Erik A. Lippa

Dose Response and Duration of Action of Dorzolamide, a Topical Carbonic Anhydrase Inhibitor

Erik A. Lippa · Archives of Ophthalmology · 1992 · 130 citations

The Application of Multiple Quality-of-Life Instruments in Individuals with Mild-to-Moderate Psoriasis

Michael B. Nichol, Jane E. Margolies, Erik A. Lippa et al. · PharmacoEconomics · 1996 · 97 citations

Multiple Quality-of-life Instruments, Quality Of Life, Life Assessment +6

Expanded clinical evaluation of lovastatin (EXCEL) study results II. Assessment of the human lens after 48 weeks of treatment with lovastatin

Alan M. Laties, Charles L. Shear, Erik A. Lippa et al. · The American Journal of Cardiology · 1991 · 79 citations

Ocular Disease, Human Lens, Expanded Clinical Evaluation +4

MK-507 versus Sezolamide

Erik A. Lippa, Joel S. Schuman, Eve J. Higginbotham et al. · Ophthalmology · 1991 · 71 citations

Medicinal Chemistry, Medicine, Mechanism Of Action +5

The Use of Dorzolamide and Pilocarpine as Adjunctive Therapy to Timolol in Patients with Elevated Intraocular Pressure

Ellen R. Strahlman, Roger Vogel, Robert Tipping et al. · Ophthalmology · 1996 · 60 citations

Hypertension, Elevated Intraocular Pressure, Adjunctive Therapy +8